Viewing Study NCT00141258


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2025-12-25 @ 10:03 PM
Study NCT ID: NCT00141258
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2005-08-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pregabalin Epilepsy Add-On Trial
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module